Company intelligence / Profile preview

LOCMEDT

Tianjin, Tianjin, Chinalocmedt.net ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

LOCMEDT has developed and commercialized several fully automatic biochemistry analyzers based on micro-fluidic technology. Their systems can deliver up to 22–30 clinical chemistry results from a small blood sample within 12 minutes. The company’s products are used globally in hospitals, research laboratories, pharmaceutical/biotech companies, and veterinary clinics

Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on LOCMEDT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LOCMEDT.

Explore the full profile